Damora Therapeutics, Inc. (DMRA) › Capital ExpendituresDamora Therapeutics, Inc. (DMRA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2021: $223.0K2022: $196.0K$196.0K2021Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$196.0K-12.1%2021$223.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share